Form 4: Vaxart CFO Phillip E. Lee Reports Stock Transaction Following RSU Vesting

Vaxart's Chief Financial Officer, Phillip E. Lee, reported the withholding of 6,132 common shares to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• Phillip E. Lee, the Chief Financial Officer of Vaxart, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction on December 15, 2024, where 6,132 shares of common stock were withheld by Vaxart.
• These shares were withheld to satisfy income tax obligations related to the vesting of Restricted Stock Units (RSUs).
• The price per share for the transaction was $0.592.
• Following the transaction, Mr. Lee beneficially owns 233,669 shares of Vaxart common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither positive nor negative, but rather a standard procedure. Therefore, the sentiment is neutral to slightly positive.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of withholding shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• The practice of withholding shares to cover taxes on vested RSUs is a standard practice across publicly traded companies.
• Many companies use similar mechanisms to manage executive compensation and tax obligations.
• This transaction is consistent with typical executive compensation practices in the biotechnology industry.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a standard procedure related to executive compensation.
• The transaction does not have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, SEC Filing, Vaxart, VXRT, Phillip E. Lee, Chief Financial Officer, RSU, Restricted Stock Units, Stock Transaction, Beneficial Ownership